In Conversation: John Mumm, Chief Executive Officer, Deka Biosciences

Published on :

John Mumm is a serial biotechnology entrepreneur who, as a young researcher, demonstrated the importance of the cytokine, interleukin -10 (IL-10), in activating the immune system to destroy tumors. That research led to the use of Pegylated IL-10 to treat patients with pancreatic cancer and other solid tumors through his work at ARMO Biosciences, a company he founded and was later acquired by Eli Lilly in 2018.

Fulton Bank Aims to be a Key Partner for the Life Science and Technology Community

Published on :

Late in 2019, Fulton Bank launched a brand-new division to support emerging Life Science and Technology companies. Many traditional banks have historically shied away from these types of companies, which often operate in pre-revenue business models that are more complicated to assess. However, if successful, these companies represent some of the greatest potential for growth and economic impact.

2021 Technology Showcase

Published on :

Hear from inventors from the National Cancer Institute and the Frederick National Laboratory about technologies primed for commercialization and/or collaboration; great opportunity for biotech stakeholders and companies of all sizes, [….]

8 TEDCO Talks for Biotech and Life Science Enthusiasts in the BHCR

TEDCO Talks
Published on :

TEDCO Talks’, a video series launched by TEDCO in November 2020, serves as a platform for individuals to hear from thought leaders on economic development in the BioHealth Capital Region (BHCR), and particularly in Maryland. These 30-minute virtual ‘fireside chats’ cover a range of topics, such as advice to small businesses dealing with COVID-19, available funding programs and benefits, diversity and inclusion, and more.

400+ Inventions, Millions In Revenues Touted By Hopkins Start-Ups

JHTV Annual Report
Published on :

“Fiscal Year 2021 was an extraordinary one for Johns Hopkins Technology Ventures despite the challenges of the pandemic,” Executive Director Christy Wyskiel told BioBuzz in an email. “We took full advantage of the momentum from the last few years.”

NCI Tech Opportunities Webinar: New HIV Vaccine to Treat and Prevent HIV

Published on :

TTC is planning a technology opportunities webinar on July 13, 2021 from 11:00 am – noon, EST. Attendees will hear from the NCI’s Dr. Genoveffa Franchini about a new HIV [….]

NCI Technology Opportunities Webinar: “Complete Tumor Regression Seen in Colon Cancer and Leukemia Animal Models with a Novel High Efficacy Fluorinated Cytidine Therapeutic Compound”

Published on :

The National Cancer Institute (NCI), Technology Transfer Center (TTC) will host a webinar to highlight a cancer therapeutic technology for collaborative development and/or licensing. The webinar presented by the technology inventor, Dr. Joel Morris, will highlight NCI’s novel, therapeutic fluorinated cytidine compound that shows high efficacy against colon cancer and leukemia. Studies indicated that the therapeutic compound can produce complete regression in xenograph mouse models with minimal effects on body weight. Registration is free.

The BioHealth Capital Region, Epicenter of U.S. Regulatory Infrastructure

Published on :

As one of the world’s top bio hubs, the BioHealth Capital Region (BHCR) is rife with life science assets. The region has been at the forefront of the SARS-CoV-2 vaccine race and it is rapidly becoming a center for advanced manufacturing. The BHCR cell and gene therapy ecosystem is thriving, and the area boasts one of the richest and most diverse tapestries of life science talent and workforce development programming. What’s more, Maryland, Washington, DC, and Virginia are home to several dynamic university systems that keep the talent and tech transfer pipeline humming and full.

‘Best Kept Secret’ MDC Provides Path for Medical Device Innovations

Published on :

In the heart of pharmaceutical and medical innovation lies an undiscovered treasure that provides a pathway for med-tech innovation, the Maryland Development Council (MDC). The council is a MedTech Startup Studio that works with inventors to develop their ideas into working prototypes and marketable products.

5 Questions with Ken Malone, Co-Founder, and Principal, Early Charm Ventures, LLC.

Published on :

Ken Malone is a co-founder of Early Charm Ventures, a venture studio founded in 2012 in Baltimore (Charm City) that converts science to business. Early Charm specializes in taking brilliant scientific discoveries made at universities and turning them into companies focused on growth. They don’t chase quick exits. They build companies that create sustainable value.